1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relapse Prevention in Stimulant Use Disorder Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion - Stimulant Use, Relapse | Early Phase 1 | Withdrawn | University of California, Los Angeles | 2023-06-11 | 2023-09-22 |
Attention Deficit Disorder with Hyperactivity (1) · Recurrence (1)
Attention Deficit and Disruptive Behavior Disorders (1) · Disease Attributes (1) · Mental Disorders (1) · Neurodevelopmental Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bupropion (1) · bupropion hydrochloride, naltrexone hydrochoride drug combination (1)
University of California, Los Angeles (1)
United States (1)